The systemic presser effects of angiotensin II (ANGII) are well descri
bed, whereas relatively little is known regarding its effects on the p
ulmonary circulation in humans. Doppler echocardiographic measurements
were performed in eight normal volunteers after a 30-min control infu
stion (baseline), after sequential 30 min stepwise infusions of ANGII
(2, 4, and 6 ng/kg/min), and again 30 min after stopping ANGII therapy
. There were significant dose-related increases in mean pulmonary arte
rial pressure and total pulmonary vascular resistance, with values ret
urning to baseline after stopping ANGII therapy. However, the increase
in vascular resistance was proportionately greater for the pulmonary
compared with systemic vascular bed, and the difference was significan
t at all doses of ANGII. Thus, the pulmonary vasculature exhibited gre
ater sensitivity to the vasoconstrictor effects of ANGII in comparison
with the systemic vasculature.